China Medicine Stock Annual Yield
| CHME Stock | USD 0.0002 0.00 0.00% |
China Medicine fundamentals help investors to digest information that contributes to China Medicine's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Medicine pink sheet.
China |
China Medicine Company Annual Yield Analysis
China Medicine's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, China Medicine has an Annual Yield of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
China Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Medicine's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Medicine could also be used in its relative valuation, which is a method of valuing China Medicine by comparing valuation metrics of similar companies.China Medicine is currently under evaluation in annual yield category among its peers.
China Fundamentals
| Return On Equity | 0.0663 | |||
| Return On Asset | 0.0782 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 2 M | |||
| Shares Outstanding | 23.71 M | |||
| Price To Earning | (6.67) X | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 64.75 M | |||
| Gross Profit | 18.98 M | |||
| EBITDA | 13.41 M | |||
| Net Income | 1.72 M | |||
| Cash And Equivalents | 7.85 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 4.05 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 11.15 X | |||
| Book Value Per Share | 1.97 X | |||
| Cash Flow From Operations | 16.96 M | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 281 | |||
| Beta | 36.82 | |||
| Market Capitalization | 284.54 K | |||
| Total Asset | 66.84 M | |||
| Retained Earnings | 24.76 M | |||
| Working Capital | 85.75 M | |||
| Current Asset | 94.2 M | |||
| Current Liabilities | 8.45 M | |||
| Z Score | 1.2 | |||
| Net Asset | 66.84 M |
About China Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.